These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11407729)

  • 1. Lipid peroxidation may predict restenosis after coronary balloon angioplasty.
    Imai K; Matsubara T; Kanashiro M; Ichimiya S; Hotta N
    Jpn Circ J; 2001 Jun; 65(6):495-9. PubMed ID: 11407729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease.
    Wykretowicz A; Dziarmaga M; Szczepanik A; Guzik P; Wysocki H
    Int J Cardiol; 2003 Jun; 89(2-3):173-8. PubMed ID: 12767540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
    Eur Heart J; 2002 May; 23(9):726-33. PubMed ID: 11977999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty.
    Li XP; Zhou SH; Tang JJ; Liu QM; Fang ZF; Hu XQ; Zhou T; Sheng XQ; Zhao SP
    Circ J; 2008 May; 72(5):729-33. PubMed ID: 18441451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemia as a risk factor for restenosis after coronary balloon angioplasty.
    Imazu M; Sumii K; Yamamoto H; Toyofuku M; Okimoto T; Gomyo Y; Ueda H; Hayashi Y; Kohno N
    Jpn Circ J; 2001 Nov; 65(11):947-52. PubMed ID: 11716244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of haematological parameters before coronary angioplasty on subsequent restenosis.
    Avci A; Boyaci A; Cağli K; Cosgun A; Gokce V; Duru E; Korkmaz S
    Acta Cardiol; 2004 Jun; 59(3):263-8. PubMed ID: 15255457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma osteopontin concentration is elevated in patients with coronary bare metal stent restenosis.
    Yilmaz KC; Bal UA; Karacaglar E; Okyay K; Aydinalp A; Yildirir A; Muderrisoglu H
    Acta Cardiol; 2018 Feb; 73(1):69-74. PubMed ID: 28841817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina.
    Mito T; Miura S; Iwata A; Morii J; Sugihara M; Ike A; Mori K; Kawamura A; Nishikawa H; Zhang B; Saku K
    Coron Artery Dis; 2011 Nov; 22(7):451-7. PubMed ID: 21811155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte CD15 expression and platelet activation in the coronary sinus after coronary intervention.
    Rauch U; Wolff UM; Schultheiss HP; Schwimmbeck PL
    Pathophysiol Haemost Thromb; 2003; 33(2):109-15. PubMed ID: 14624053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
    L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
    Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty.
    Parfyonova Y; Alekseeva I; Plekhanova O; Deev A; Titaeva E; Dobrovolsky A; Gabbasov Z; Lyakishev A; Tkachuk V
    Heart Vessels; 2014 Sep; 29(5):611-8. PubMed ID: 24057344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.
    Jeong WK; Jeong MH; Kim KH; Lee SR; Park OY; Yum JH; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Ahn BH; Suh SP; Park JC; Kim SH; Kang JC
    Korean J Intern Med; 2003 Sep; 18(3):154-60. PubMed ID: 14619384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis.
    Cipollone F; Fazia M; Iezzi A; Pini B; Costantini F; De Cesare D; Paloscia L; Materazzo G; D'Annunzio E; Bucciarelli T; Vecchiet J; Chiarelli F; Cuccurullo F; Mezzetti A
    Heart; 2003 Jul; 89(7):773-9. PubMed ID: 12807855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty. Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial.
    Lloyd GW; Jackson G; Foley DP; Boersma E; Shepherd J; Serruys PW
    Atherosclerosis; 2001 Oct; 158(2):445-54. PubMed ID: 11583725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes.
    Verheye S; Vrolix M; Kumsars I; Erglis A; Sondore D; Agostoni P; Cornelis K; Janssens L; Maeng M; Slagboom T; Amoroso G; Jensen LO; Granada JF; Stella P
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2029-2037. PubMed ID: 28964764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.